Anticardiolipin antibodies leptospirosis clinical course serology cases leptospirosis area high endemic infection rate insight pathology secondary immune phase typical disease IgG antibody concentrations immunoassay cases severe disease patients uncomplicated leptospirosis IgG anticardiolipin concentrations control reference range unreported association leptospira vascular endothelial injury severe cases expose crypt antigens conformational change cell surface phospholipids Leptospirosis model infective origin cases antiphospholipid syndrome 